In a newly released documentary, Kim Seok-jin, a Member of the globally renowned K-pop group BTS, disclosed that he required medical intervention multiple times due to health issues prior to reuniting with his bandmates for a scheduled event in Los Angeles. The revelation was made in the documentary “BTS: The Return,” which chronicles the group’s activities surrounding their 2022 “Yet to Come in Busan” concert and subsequent gatherings. Jin stated he received intravenous drips on five separate occasions to manage his condition before traveling to join the other members.
Context of the Disclosure
The disclosure occurred during the documentary’s coverage of the period following BTS’s announcement in June 2022 that they would be focusing on individual projects. This pause in group activities was framed as a necessary step for artistic growth. During this time, the members pursued solo endeavors while also fulfilling pre-arranged group commitments. One such commitment was a meeting in Los Angeles in late 2022, intended for group discussions and photo shoots.
It was in the lead-up to this Los Angeles meeting that Jin experienced health problems. The specifics of his medical condition were not detailed in the documentary excerpt. The use of IV drips, or intravenous therapy, is a common medical procedure for delivering fluids, medications, or nutrients directly into the bloodstream, often used to address dehydration, nutrient deficiencies, or to aid recovery.
Fan Reaction and Industry Scrutiny
News of Jin’s health disclosure prompted a significant emotional response from the group’s global fanbase, known as ARMY. Many expressed concern and sympathy on social media platforms, highlighting the intense physical and mental pressures faced by idols in the K-pop industry. The industry is known for its rigorous training systems, packed schedules, and high-performance demands, which have long been a topic of discussion regarding artist welfare.
This incident has renewed conversations about the sustainability of such demanding entertainment schedules and the duty of care owed by management companies to their artists. BTS’s label, HYBE, has previously addressed concerns about the group’s workload, emphasizing efforts to balance activity with rest. Jin’s candid admission provides a concrete, personal example of the health costs that can accompany superstar status.
Official Statements and Forward Path
As of the documentary’s release, neither Jin nor HYBE has issued additional statements elaborating on the nature of his illness at that time. The documentary itself serves as the primary source for this information. The other BTS members are currently fulfilling their mandatory military service in South Korea, a process Jin initiated in December 2022. The group is expected to reconvene in 2025 following the completion of all members’ service obligations.
The full group’s next official activities are anticipated to commence after 2025. In the interim, the members continue to engage with fans through pre-recorded content and individual projects released according to their personal schedules and service commitments. The documentary “BTS: The Return” offers a behind-the-scenes look at a transitional period for the group, with Jin’s health revelation underscoring the human realities behind their global phenomenon.
Source: Mashable
